Kean Family Partnership Johnson & Johnson Common Stock
Recent activity from public SEC and congressional filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Thomas H. KeanNJ07 | House | Sell | $1,001 - $15,000 | Jun 29, 2026 |
| Lloyd DoggettTX37 | House | Buy | $1,001 - $15,000 | Jun 9, 2026 |
| Thomas H. KeanNJ07 | House | Sell | $1,001 - $15,000 | Jun 2, 2026 |
| Alan ArmstrongArmstrong, Alan (Senator) | Senate | Buy | $1,001 - $15,000 | Mar 30, 2026 |
| Alan ArmstrongArmstrong, Alan (Senator) | Senate | Buy | $15,001 - $50,000 | Mar 27, 2026 |
| Thomas H TubervilleTuberville, Tommy (Senator) | Senate | Sell | $15,001 - $50,000 | Oct 29, 2024 |
Source: Senate eFD and House Clerk STOCK Act disclosures
MySmarTrend Analysis
Context for JNJ
Related research and newsletter analysis explaining the company, its market, and notable insider activity.
10 Recession and Tariff-Proof Stocks Worth Watching
When the macro environment gets ugly — recession fears, tariff uncertainty, rate pressure — the same categories of stocks tend to hold up. These 10 have the characteristics that matter when things get rough.
Read the analysis →Dividend Investing Strategy for 2026: Build Real Passive Income
Dividend investing isn't about chasing the highest yields — it's about building a durable income stream. Here's the strategy that actually works in 2026.
Read the analysis →Get notable JNJ activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.